Display options
Cite
Tanei R. Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly. J Clin Med. 2015;4(5):979-97doi: 10.3390/jcm4050979.
Tanei, R. (2015). Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly. Journal of clinical medicine, 4(5), 979-97. https://doi.org/10.3390/jcm4050979
Tanei, Ryoji. "Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly." Journal of clinical medicine vol. 4,5 (2015): 979-97. doi: https://doi.org/10.3390/jcm4050979
Tanei R. Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly. J Clin Med. 2015 May 18;4(5):979-97. doi: 10.3390/jcm4050979. PMID: 26239460; PMCID: PMC4470211.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2015 May 18;4(5):979-97. doi: 10.3390/jcm4050979.

Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly.

Journal of clinical medicine

Ryoji Tanei

Affiliations

  1. Departments of Dermatology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakaecho, Itabashi, Tokyo 173-0015, Japan. [email protected].

PMID: 26239460 PMCID: PMC4470211 DOI: 10.3390/jcm4050979

Abstract

Atopic eczema (AE) in the elderly is gradually increasing and has been added to the classification of AE in recent years. This investigation retrospectively analyzed 60 patients with elderly AE. Among the clinical characteristics, a male predominance, existence of several patterns of onset and clinical course, and associations with immunoglobulin (Ig)E-allergic-status and asthmatic complication were observed. The highest positive-rate and positive-score for serum-specific IgE against Dermatophagoides farinae were 83.8% and 2.65 in patients with IgE-allergic AE, and a lower incidence of lichenified eczema in the elbow and knee folds were observed. In terms of treatments and outcomes, clinical improvement and clinical remission were observed in 80.8% and 36.5% of cases, respectively, using standard treatments and combined therapy with oral corticosteroid in severe cases. As for complications and final prognosis, most elderly AE patients reached the end of life with AE, but patients with IgE-allergic AE showed significantly lower incidences of complications of malignancy and death from malignancy. These results indicate that AE in the elderly represents a new subgroup of AE with specific features.

Keywords: atopic eczema; clinical characteristics; complications; elderly; immunoglobulin E; onset; outcomes; prognosis; skin manifestations; treatment

References

  1. Br J Dermatol. 2007 Oct;157(4):645-8 - PubMed
  2. J Am Acad Dermatol. 2008 Mar;58(3):407-14 - PubMed
  3. J Allergy Clin Immunol. 2006 Sep;118(3):543-8; quiz 549-50 - PubMed
  4. Br J Dermatol. 2007 Apr;156(4):693-7 - PubMed
  5. J Dermatol. 2014 Mar;41(3):200-4 - PubMed
  6. Br J Dermatol. 2006 Feb;154(2):205-10 - PubMed
  7. Br J Dermatol. 2014 Jul;170 Suppl 1:44-8 - PubMed
  8. J Invest Dermatol. 2005 Sep;125(3):445-9 - PubMed
  9. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):12-8 - PubMed
  10. Br J Dermatol. 1998 Nov;139(5):834-9 - PubMed
  11. Allergy. 2013 Aug;68(8):974-82 - PubMed
  12. J Eur Acad Dermatol Venereol. 2013 Aug;27(8):952-60 - PubMed
  13. J Dermatol. 2008 Sep;35(9):562-9 - PubMed
  14. Allergy. 2012 Dec;67(12):1475-82 - PubMed
  15. J Dermatol. 2009 Oct;36(10):563-77 - PubMed
  16. Inflamm Allergy Drug Targets. 2009 Dec;8(5):398-404 - PubMed
  17. Int Arch Allergy Immunol. 2012;157(4):372-8 - PubMed
  18. Allergy. 2000 Mar;55(3):240-5 - PubMed
  19. J Allergy Clin Immunol. 2013 Aug;132(2):361-70 - PubMed
  20. Bone Marrow Transplant. 2013 Mar;48(3):452-8 - PubMed
  21. Arch Dermatol. 2005 Sep;141(9):1123-7 - PubMed
  22. J Invest Dermatol. 2007 Mar;127(3):724-6 - PubMed
  23. Br J Dermatol. 2006 Oct;155(4):778-83 - PubMed
  24. J Dtsch Dermatol Ges. 2012 Mar;10(3):174-8 - PubMed
  25. Dermatology. 2015;230(1):62-9 - PubMed

Publication Types